SCHEMBL1126512

SCHEMBL1126512

COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(N4CCN(C(C)C)CC4)nc3)c3ncc(-c4nc(C(N)=O)c(C(N(C)C)N(C)C)[nH]4)nc23)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 19/20 0.53
IKBKB O14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127090 0.80 FGFR3 (0.81) FGFR3
SCHEMBL1126675 0.71 FGFR3 (0.80) FGFR3
SCHEMBL12678227 0.71 FGFR3 (1.00) FGFR3
SCHEMBL17023101 0.70 FGFR3 (0.64) FGFR3
SCHEMBL1126244 0.70 FGFR3 (1.00) FGFR3
SCHEMBL1127041 0.67 FGFR3 (0.62) FGFR3
SCHEMBL12678228 0.67 FGFR3 (1.00) FGFR3
SCHEMBL1126299 0.64 FGFR3 (0.70) FGFR3
SCHEMBL1126308 0.63 FGFR3 (0.78) FGFR3
SCHEMBL1126459 0.62 FGFR3 (0.84) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS Novartis AG (CH) 2011-02-16 EP claimed